Daewoong to reinforce anticancer drug business.

Published: 2006-04-06 06:57:00

Updated: 2006-04-06 06:57:00

In strategic alliance with Reyon Pharm. for the anti-cancer and immunity suppressant drug business, Daewoong has agreed an MOU to reinforce the anti-cancer drug business in the future.

Reyon Pharm has developed a lot of chemical synthetic and fermentation technologies for the anti-cancer and i...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK